Karolinska Universitetssjukhuset ( Site 0051)

Solna 171 64

0 studies enrolling now · 1 studies all time

What they study most

Advanced Melanoma

Studies at this site

• Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) for Advanced Melanoma in Anti-Programmed Death-1/Programmed Death-Ligand 1 (PD-1/L1)-Exposed Participants (MK-7902-004/E7080-G000-225/LEAP-004) — Completed